The purpose of The PROSPECT Study is to evaluate an investigational medication for the treatment of moderate to severe ulcerative colitis. This study is being conducted at up to 38 clinical research centers in the US, Canada, and Belgium, and is open to male and female patients 12 years and older. Participants in the study will have a number of visits to a research center over a five-month period. All study related care and medication is provided to qualified participants at no cost: this includes all visits, examinations, and laboratory work.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
150
Clinical Research Associates
Huntsville, Alabama, United States
Advanced Medical Research Institute
Anaheim, California, United States
Research Foundation of America
Los Angeles, California, United States
Western Gastroenterology Group
Los Angeles, California, United States
Cedar Sinai Medical Center
Los Angeles, California, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GVAMC
Gainesville, Florida, United States
Clinical Research Associates
Hollywood, Florida, United States
Physician Office
Jacksonville, Florida, United States
Mount Sinai Medical Center
North Miami Beach, Florida, United States
Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
...and 25 more locations